Loading…
Inhibition of Breast Cancer Resistance Protein (BCRP) by Ko143 Can Affect Pharmacokinetics of Enrofloxacin in Exopalaemon carinicauda
Adenosine triphosphate-binding cassette transporter breast cancer resistance protein (BCRP) exists highly in the apical membranes of epithelia, and is involved in drug availability. Ko143 is a typical inhibitor of BCRP in rodents. The synthetic antibacterial agent enrofloxacin (ENRO) is a fluoroquin...
Saved in:
Published in: | Journal of Ocean University of China 2020-10, Vol.19 (5), p.1116-1124 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Adenosine triphosphate-binding cassette transporter breast cancer resistance protein (BCRP) exists highly in the apical membranes of epithelia, and is involved in drug availability. Ko143 is a typical inhibitor of BCRP in rodents. The synthetic antibacterial agent enrofloxacin (ENRO) is a fluoroquinolone employed as veterinary and aquatic medicine, and also a substrate for BCRP.
BCRP
gene highly expressed in the hepatopancreas and intestine of
Exopalaemon carinicauda
as was determined with real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR) method. The effects of Ko143 on the abundance of
BCRP
mRNA and ENRO pharmacokinetics in
E. carinicauda
were studied. The mRNA abundance of
BCRP
decreased significantly in hepatopancreas and intestine (
P |
---|---|
ISSN: | 1672-5182 1993-5021 1672-5174 |
DOI: | 10.1007/s11802-020-4312-9 |